133 related articles for article (PubMed ID: 15537484)
1. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes.
Cavendish JJ; Fugit RV; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1839-43. PubMed ID: 15537484
[TBL] [Abstract][Full Text] [Related]
2. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).
Lim MJ; Eagle KA; Gore JM; Anderson FA; Dabbous OH; Mehta RH; Granger CB; Fox KA; Spencer FA; Goldberg RJ;
Am J Cardiol; 2005 Oct; 96(7):917-21. PubMed ID: 16188516
[TBL] [Abstract][Full Text] [Related]
3. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
4. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
Umman B
Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
Puma JA; Sketch MH
J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
7. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of clopidogrel in acute coronary syndrome.
Zambahari R; Kwok OH; Javier S; Mak KH; Piyamitr S; Tri Ho HQ; Hwang JJ; Suryawan R; Chow WH
Int J Clin Pract; 2007 Mar; 61(3):473-81. PubMed ID: 17313616
[TBL] [Abstract][Full Text] [Related]
9. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
[TBL] [Abstract][Full Text] [Related]
10. [Two year follow-up of acute ischemic syndrome without ST elevation].
Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
[TBL] [Abstract][Full Text] [Related]
11. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
[TBL] [Abstract][Full Text] [Related]
12. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
Cantor WJ; Goodman SG; Cannon CP; Murphy SA; Charlesworth A; Braunwauld E; Langer A
Am Heart J; 2005 Feb; 149(2):275-83. PubMed ID: 15846265
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic therapy for non-ST segment elevation myocardial infarction].
Hölschermann H
Hamostaseologie; 2006 May; 26(2):106-13. PubMed ID: 16676052
[TBL] [Abstract][Full Text] [Related]
14. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
[TBL] [Abstract][Full Text] [Related]
15. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
18. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Bottorff MB; Nutescu EA; Spinler S
Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
[TBL] [Abstract][Full Text] [Related]
20. Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management.
Kou V; Nassisi D
Mt Sinai J Med; 2006 Jan; 73(1):449-68. PubMed ID: 16470325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
